ALNY Competitors & Alternatives
Compare Alnylam Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
ALNY
Main Stock$312.78
Tradestie Score
64
Market Cap
$60.38B
P/E Ratio
75.8
Revenue Growth
1.0%
Analyst Upside
+39.0%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
REGN
Regeneron Pharmaceuticals Inc
|
$654.27
|
$63.59B | 15.2 | 63 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$939.68
|
$46.96B | 41.7 | 62 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$297.65
|
$36.81B | 65.8 | 59 | Compare |
|
INSM
Insmed, Inc.
|
$111.60
|
$31.13B | - | 54 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$97.55
|
$24.57B | - | 56 | Compare |
|
GMAB
Genmab A/S ADS
|
$28.52
|
$19.56B | 20.9 | 63 | Compare |
|
INCY
Incyte Genomics Inc
|
$116.86
|
$16.93B | 16.1 | 61 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$57.77
|
$15.70B | 29.4 | 63 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$15.42
|
$15.22B | - | 49 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$174.26
|
$13.59B | 25.8 | 62 | Compare |
More ALNY Analysis
Data updated: Jul 03, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry